International Scholarly Research Notices

International Scholarly Research Notices / 2013 / Article

Clinical Study | Open Access

Volume 2013 |Article ID 845876 | 6 pages |

Development of Dengue Infection Severity Score

Academic Editor: K. Tokiwa
Received13 Jul 2013
Accepted12 Sep 2013
Published12 Nov 2013


Objectives. To develop a simple scoring system to predict dengue infection severity based on patient characteristics and routine clinical profiles. Methods. Retrospective data of children with dengue infection from 3 general hospitals in Thailand were reviewed. Dengue infection was categorized into 3 severity levels: dengue infection (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS). Coefficients of significant predictors of disease severity under ordinal regression analysis were transformed into item scores. Total scores were used to classify patients into 3 severity levels. Results. Significant clinical predictors of dengue infection severity were age >6 years, hepatomegaly, hematocrit 40%, systolic pressure <90 mmHg, white cell count >5000 /μL, and platelet ≤50000 /μL. The derived total scores, which ranged from 0 to 18, classified patients into 3 severity levels: DF (scores <2.5, , 58.1%), DHF (scores 2.5–11.5, , 35.5%), and DSS (scores >11.5, , 6.4%). The derived score correctly classified patients into their original severity levels in 60.7%. An under-estimation of 25.7% and an over-estimation of 13.5% were clinically acceptable. Conclusions. The derived dengue infection severity score classified patients into DF, DHF, or DSS, correctly into their original severity levels. Validation of the score should be reconfirmed before application of routine practice.

1. Introduction

Dengue infection has become an international public health burden. Half of the world population are presently at risk of dengue infection. Approximately 50–100 million infected cases were reported annually. Among those infected, 500000 patients had severe infection and required hospital admission; most were children. Approximately 2.5% died from the infection [1]. The cost of care was as high as $US 2.1 billion per year in The United States of America [2]. No specific treatments are available except for symptomatic [3], which are effective in early detection [4]. In patients with severe infection, shock and hemorrhage usually follow [4, 5]. If not treated, death may be a consequence. Early detection or correct prognostication may avoid such severe complications [4, 6].

Clinical risks and various laboratory results were studied to explore their roles in the prediction of dengue severity. Among many of them were girls [7], children above 5 years of age [8], persistent abdominal pain [9], lethargy, cold hand and feet [10], hepatomegaly [11], abnormal bleeding [12], overweight [13], malnourished children [14], ascites [8], plural effusion [15], leucopenia (white blood count < 4,000/ L) [8], thrombocytopenia [16], hemoconcentration [16], prolonged prothrombin time (PT) [16], prolonged partial thromboplastin time (PTT) [17], elevated aspartate aminotransferase (AST), and alanine aminotransferase (ALT) enzymes [18].

The scoring system, such as the Pediatric Logistic Organ Dysfunction (PELOD) Score and the Disseminated Intravascular Coagulation (DIC) Score, was used to forecast mortality in DSS [19]. A decision tree algorithm was used to differentiate dengue fever from other types of fever and also to forecast severity in dengue infection [20]. Some studies applied DIC scoring system to diagnose DIC more precisely, using clinical signs and symptoms and routine laboratory investigations to differentiate DHF from DF [21]. Most of the prediction systems in the past focused on clinical outcomes of the disease. There are few studies that focused directly on dengue infection severity.

The aim of the present study was to develop a simple clinical risk scoring system to predict dengue infection severity, based on patient clinical characteristics and routine laboratory investigations, obtained from the previous investigation [22].

2. Materials and Methods

2.1. Patients

The medical records of children aged 1–15 years with dengue infection between 2007 to 2010 in the three university-affiliated general hospitals located in the northern region of Thailand, Sawanpracharak Hospital in Nakorn Sawan, Uttaradit Hospital in Uttaradit, and Kamphaeng Phet Hospital in Kamphaeng Phet, were reviewed. The data were retrieved from the hospital database, under the following ICD-10: A90-dengue fever, A91-dengue hemorrhagic fever, and A910-dengue hemorrhagic fever with shock.

2.2. Indicator Parameters

The patient characteristics with potential prediction included(1)demographic: gender and age;(2)mode of presentation: hepatomegaly, headache, myalgia, vomiting, cough, abdominal pain, rash, pleural effusion, petechiae, and any bleeding episodes;(3)hemodynamic profiles: pulse pressure, systolic blood pressure (SBP), and diastolic blood pressure (DBP);(4)hematological profiles: hematocrit, hemoglobin, white cell count, lymphocytes, neutrophils, and platelet;(5)biochemical profiles: aspartate aminotransferase (AST), alanine aminotransferase (ALT), prothrombin time (PT), and partial thromboplastin time (PTT).

2.3. Definition of Dengue Severity

The severity of dengue infection was operationally defined by the following criteria:(1)dengue infection (DF): acute or abrupt onset of fever, accompanied by a positive tourniquet test, and white blood count ≤ 5,000/μL [23];(2)dengue hemorrhagic fever (DHF): all of the following items [24]:(i)acute or abrupt fever for 2–7 days,(ii)at least one of the following bleeding episodes:(a)positive tourniquet test,(b)petechiae, ecchymoses, or purpura,(c)bleeding from mucosa, gastrointestinal tract, injection sites, or other location,(d)hematemesis or melena,(iii)platelet ≤ 100,000/μL,(iv)at least one of the following plasma leakage evidence items:(a)hemoconcentration assessed by an increase in hematocrit ≥20% from previous hematocrit,(b)signs of plasma leakage, such as pleural effusion or ascites, or evidence of hypoalbuminemia;(3)dengue shock syndrome (DSS): all items for dengue hemorrhagic fever above, accompanied with evidence of circulatory failure [24]:(i) rapid and weak pulse,(ii) pulse pressure ≤ 20 mmHg,or manifested by(i) hypotension,(ii) cold body temperature or irritable.

Dengue severity was classified into 4 grades, based on bleeding episodes and shock, as follows:grade 1: no evidence of bleeding, Positive Tourniquet test,grade 2: evidences of bleeding episodes,grade 3: presence of week and rapid pulse rate, low blood pressure, or narrow pulse pressure,grade 4: nonmeasurable blood pressure or nonpalpable pulse.grades 1-2 were classified as DHF and grades 3-4 were classified as DSS [24].

2.4. Data Analysis

Potential predictors for dengue severity from a previous report [22] were tested with nonparametric test for trend. The predictive ability was analyzed by multivariable ordinal logistic regression and presented with coefficients and odds ratios. Missing data were replaced by the mean values of the parameters. Assigned item scores were derived by transformation of coefficient of parameters. The total (sum) scores were used to classify patients into 3 severity levels. The distribution of scores across the three severity groups were presented with box plots. The discriminative and predictive abilities of the scores were presented with probability curves.

2.5. Ethical Approval

The present investigation was approved by the Research Ethical Committee of the Faculty of Medicine, Chiang Mai University, and the research ethical committees of the three hospitals.

3. Results

A total of 777 patients with dengue infection were classified based on the above criteria into 3 severity levels: DF ( ), DHF ( ), and DSS ( ).

3.1. Significant Predictors

Under the univariable analysis, the three severity groups were similar in gender ( = 0.888), age ( = 0.903), presence of vomiting ( = 0.187), cough ( = 0.425), rash ( = 0.124), and DBP ( = 0.084) but were difference according to the presence of hepatomegaly, headache, myalgia, abdominal pain, pleural effusion, petechiae, bleeding episodes, SBP, pulse pressure, hematocrit, hemoglobin, white cell count, lymphocytes, neutrophils, platelets, AST, ALT, PT, and PTT (Table 1).

Patient profilesDF ( )DHF ( )DSS ( ) value*
Mean ± SDMean ± SDMean ± SD

 Male ( , %)185 (47.3)153 (51.7)38 (42.2)0.888
 Age (year) 0.903
Mode of presentation
 Hepatomegaly ( , %)8 (2.1)26 (8.8)55 (61.1)<0.001
 Headache ( , %)228 (58.3)145 (49.0)35 (38.9)<0.001
 Myalgia ( , %)84 (21.5)30 (10.1)12 (13.3)0.001
 Vomiting ( , %)244 (62.4)216 (73.0)56 (62.2)0.187
 Cough ( , %)120 (30.7)94 (31.8)32 (35.6)0.425
 Abdominal pain ( , %)160 (40.9)181 (61.2)60 (66.7)<0.001
 Rash ( , %)166 (42.5)132 (44.6)26 (28.9)0.124
 Pleural effusion ( , %)0 (0)20 (6.8)34 (37.8)<0.001
 Petechiae ( , %)27 (6.9)26 (8.8)14 (15.6)0.016
 Any bleeding episodes ( , %)73 (18.7)80 (27.0)51 (56.7)<0.001
 SBP (mmHg) <0.001
 DBP (mmHg) 0.084
 Pulse pressure (mmHg) <0.001
 Hematocrit (%) <0.001
 Hemoglobin (g/dL) <0.001
 White cell count (/µL) <0.001
 Lymphocytes (%) <0.001
 Neutrophils (%) <0.001
 Platelet (/µL) <0.001
 AST (U/L) <0.001
 ALT (U/L) 0.001
 PT (sec) 0.012
 PTT (sec) 0.004
Case management
 Inbound referral ( , %)43 (11.0)78 (26.4)48 (53.3)<0.001
  Alive ( , %)391 (100.0)296 (100.0)88 (97.8)1.000
  Outbound referral ( , %)0 (0)0 (0)2 (2.2)
  In hospital dead ( , %)0 (0)0 (0)0 (0)

value from nonparametric test for trend.
SD: standard deviation; SBP: systolic blood pressure; DBP: diastolic blood pressure; AST: aspartate aminotransferase; ALT: alanine aminotransferase; PT: prothrombin time; PTT: partial thromboplastin time.

Under the multivariable analysis, the clinical characteristics with significant predictive ability for dengue severity included age > 6 years (OR = 1.46, 95% CI = 1.12–1.91, ), hepatomegaly (OR = 12.31, 95% CI = 8.84–17.15, ), hematocrit ≥ 40% (OR = 1.34, 95% CI = 1.10–1.64, ), SBP < 90 mmHg (OR = 1.70, 95% CI = 1.32–2.17, ), white cell count > 5000/μL (OR = 1.40, 95% CI = 1.13–1.75, ), and platelet ≤ 50000/μL (OR = 3.95, 95% CI = 3.14–4.96, ). The strongest predictors were hepatomegaly (OR = 12.31) and platelet ≤ 50000/μL (OR = 3.95) (Table 2).

PredictorsCategoryOR95% CI valueCoefficient*Score

Age (year)>61.461.12–1.910.0050.381
Hematocrit (%)≥401.341.10–1.640.0030.301
SBP (mmHg)<901.701.32–2.17<0.0010.532
White cell count (/µL)>50001.401.13–1.750.0020.341
Platelet (/µL)≤500003.953.14–4.96<0.0011.374.5

Coefficients from multivariable ordinal logistic regression. OR: odds ratio; CI: confidence interval; ref: reference category; SBP: systolic blood pressure.
3.2. The Scoring System

Transformation of significant parameter coefficients into item scores was done by division of each coefficient with the smallest coefficient of the model (0.30) and rounded up or down to the nearest 0.5 integers. The item scores ranged from 0 to 8.5, and the total score ranged from 0 to 18 (Table 2).

3.3. Discriminations

The mean total severity scores in patients with DF, DHF, and DSS were , , and (Table 3). The distribution of the derived severity scores was different among the three severity groups (Figure 1). The derived scores also discriminated DHF from DF and also discriminated DSS from DHF (Figure 2).

Severity score levelsScore rangeSeverity levelsRisk estimation validity*
DF ( )DHF ( )DSS ( )Over (%)Correct (%)Under (%)

Mean ± SD

DF ( )<2.5297149538.219.8
DHF ( )2.5–11.5941364612.117.55.9
DSS ( )>11.5011391.45.0


Percentage of total patients.
SD: standard deviation; IQR: interquartile range.
3.4. Clinical Predictions

Our scoring system discriminated DSS and DHF from DF with an area under the receiver operation curve (AuROC) of 0.7416 (95% CI = 0.7294–0.7537, figure not shown) and discriminated DSS from DHF and DF with a higher AuROC of 0.8877 (95% CI = 0.8788–0.8964, figure not shown).

Cut-off points were assigned to classified patients as 3 severity groups: scores <2.5 (DF), scores 2.5–11.5 (DHF), and scores >11.5 (DSS). The score <2.5 predicted DF correctly in 297 out of 391 patients with 1-level underestimation in 149 patients (19.2%) and 2-level underestimation in 5 patients (0.6%) or a total of 19.8% underestimation.

The scores between 2.5 and 11.5 predicted DHF correctly in 136 out of 296 patients, with an underestimation in 46 patients (5.9%) and an overestimation in 94 patients (12.1%).

The scores >11.5 predicted DSS correctly in 39 out of 90 patients, with 1-level overestimation in 1 out of 11 patients (1.4%), with no 2-level overestimation (0%), or a total of 1.4% overestimation (Table 3).

4. Discussions

Dengue infection is an urgent condition requiring prompt diagnosis and treatment before patients enter into bleeding or shock states. Previous scoring systems trying to evaluate or forecast disease severity included the Dengue Fever Scoring System based on epidemiological information and clinical signs or symptoms, which might be useful in detecting DF very early prior to laboratory results [25]. Other scoring systems were the Pediatric Logistic Organ Dysfunction (PELOD) Score and the Pediatric Risk of Mortality III (PRISM III), used to evaluate the mortality rates [26], and the Disseminate Intravascular Coagulation (DIC) Score to diagnose DIC and to discriminate DF and DHF from other febrile illnesses [27].

Decision tree algorithms were also applied to classify dengue infections into DF, DHF grade I, DHF grade II, and DHF grade III [28]. They may also predict patients with low risk who may be discharged safely and select patients with high risk who should be admitted for close monitoring [29].

These studies used clinical symptoms and/or laboratory tests to evaluate or forecast the risks. Some studies included only adult patients [25, 29] which may or may not be relevant for children. In studies which included children, some studies used information on the first few days of admission in pediatric intensive care unit (PICU) [19]. In some studies, included DHF patients did not experience shock and may not be inferred to patients with DSS [21]. Risk prediction in many studies was based on nonroutine laboratory investigations [19, 20, 26, 28, 29]. Despite their high predictive powers, those nonroutine predictors were not available in many primary care centers. An investment on such facilities may not be feasible and may not be cost effective.

Our study developed a scoring system based on clinical risk and routine laboratory parameters and categorized patients with dengue infection into DF, DHF, or DSS.(1)Patients scoring <2.5 were classified as DF which is the mildest form. These patients normally do not require hospital admission even in the feverish stage. Patients may safely be handled as outpatients with symptomatic treatments and may be advised to observe any abnormal signs or symptoms with a follow-up appointment.(2)Patients scoring between 2.5 and 11.5 were classified as a risk group for DHF. These patients should be admitted to be closely monitored for early signs of plasma leakage, hemoconcentration, coagulopathy, thrombocytopenia.(3)Patients scoring >11.5 were classified as a risk group for DSS. These patients should also be admitted to monitor any early signs of shock.

Our scoring system predicted DSS correctly with a positive predictive value (PPV) of 88%, similar to other studies which reported a PPV of 82–95% [20, 26]. The score may be used to discriminate DSS from DF and DHF.

However, the fact that the derived scores in DF and DHF were more or less overlapping made it less likely to be used to differentiate DHF for DF. Other nonroutine predictors specifically for DHF may be required.

In case of continuous routine laboratory investigations, our score may also be used to monitor the patients risk for DSS as the disease progresses from day to day. In case of outpatients, this will help clinicians make decision when to admit the patients to hospital. Application of this scoring system into routine patient care may help reduce unnecessary admission and also reduce case facility in severe cases that are admitted based on high risk scores.

5. Conclusions

The derived dengue infection severity score classified patients into DF, DHF, or DSS, correctly into their original severity levels. Validation of the score should be reconfirmed before application into routine practice.

Conflict of Interests

This investigation was partially supported by the Research Grant for Basic and Applied Sciences, the Faculty of Medicine, Chiang Mai University.


The authors wish to thank the authorities of the three hospitals for their support in data collection and wish to thank the Faculty of Medicine, Chiang Mai University, for the partial grant support.


  1. World Health Organization, “Dengue and dengue haemorrhagic fever,” Fact sheet no. 117, World Health Organization, Geneva, Switzerland, 2008, View at: Google Scholar
  2. D. S. Shepard, L. Coudeville, Y. A. Halasa, B. Zambrano, and G. H. Dayan, “Economic impact of dengue illness in the Americas,” American Journal of Tropical Medicine and Hygiene, vol. 84, no. 2, pp. 200–207, 2011. View at: Publisher Site | Google Scholar
  3. Y. K. Sarin, S. Singh, and T. Singh, “Dengue viral infection,” Indian Pediatrics, vol. 35, no. 2, pp. 129–137, 1998. View at: Google Scholar
  4. M. G. Guzmán and G. Kourí, “Dengue diagnosis, advances and challenges,” International Journal of Infectious Diseases, vol. 8, no. 2, pp. 69–80, 2004. View at: Publisher Site | Google Scholar
  5. C. X. T. Phuong, N. T. Nhan, R. Kneen et al., “Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the World Health Organization classification system helpful?” American Journal of Tropical Medicine and Hygiene, vol. 70, no. 2, pp. 172–179, 2004. View at: Google Scholar
  6. M. Neeraja, V. Lakshmi, V. D. Teja, P. Umabala, and M. V. Subbalakshmi, “Serodiagnosis of dengue virus infection in patients presenting to a tertiary care hospital,” Indian Journal of Medical Microbiology, vol. 24, no. 4, pp. 280–282, 2006. View at: Google Scholar
  7. K. L. Anders, N. M. Nguyet, N. V. V. Chau et al., “Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam,” American Journal of Tropical Medicine and Hygiene, vol. 84, no. 1, pp. 127–134, 2011. View at: Publisher Site | Google Scholar
  8. V. Gupta, T. P. Yadav, R. M. Pandey et al., “Risk factors of dengue shock syndrome in children,” Journal of Tropical Pediatrics, vol. 57, no. 6, pp. 451–456, 2011. View at: Publisher Site | Google Scholar
  9. J. Junia, H. Garna, and D. Setiabudi, “Clinical risk factors for dengue shock syndrome in children,” Paediatrica Indonesiana, vol. 47, no. 1, pp. 7–11, 2007. View at: Google Scholar
  10. S. B. Halstead and L. C. Lum, “Assessing the prognosis of dengue-infected patients,” F1000 Medicine Reports, vol. 1, article 73, 2009. View at: Google Scholar
  11. A. K. I. Falconar and C. M. E. Romero-Vivas, “Simple prognostic criteria can definitively identify patients who develop severe versus non-severe dengue disease, or have other febrile illnesses,” Journal of Clinical Medicine Research, vol. 4, no. 1, pp. 33–44, 2012. View at: Google Scholar
  12. T. Tantracheewathorn and S. Tantracheewathorn, “Risk factors of dengue shock syndrome in children,” Journal of the Medical Association of Thailand, vol. 90, no. 2, pp. 272–277, 2007. View at: Google Scholar
  13. N. Pichainarong, N. Mongkalangoon, S. Kalayanarooj, and W. Chaveepojnkamjorn, “Relationship between body size and severity of dengue hemorrhagic fever among children aged 0–14 years,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 37, no. 2, pp. 283–288, 2006. View at: Google Scholar
  14. S. Kalayanarooj and S. Nimmannitya, “Is dengue severity related to nutritional status?” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 36, no. 2, pp. 378–384, 2005. View at: Google Scholar
  15. K. Alam, S. A. S. Sulaiman, A. A. Shafie, and E. Yusuf, “Clinical manifestations and laboratory profile of dengue fever among the patient’s general Hospital, Penang,” Archives of Pharmacy Practice, vol. 1, no. 1, pp. 25–29, 2010. View at: Google Scholar
  16. A. Chuansumrit, C. Puripokai, P. Butthep et al., “Laboratory predictors of dengue shock syndrome during the febrile stage,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 41, no. 2, pp. 326–332, 2010. View at: Google Scholar
  17. I. Shah, G. C. Deshpande, and P. N. Tardeja, “Outbreak of dengue in Mumbai and predictive markers for dengue shock syndrome,” Journal of Tropical Pediatrics, vol. 50, no. 5, pp. 301–305, 2004. View at: Publisher Site | Google Scholar
  18. F. R. F. G. Azin, R. P. Gonçalves, M. H. D. S. Pitombeira, D. M. Lima, and I. C. Branco, “Dengue: profile of hematological and biochemical dynamics,” Revista Brasileira de Hematologia e Hemoterapia, vol. 34, no. 1, pp. 36–41, 2012. View at: Publisher Site | Google Scholar
  19. L. P. Dewi and E. Nurfitri, “Pediatric logistic organ dysfunction score as a predictive tool of dengue shock syndrome outcomes,” Paediatrica Indonesiana, vol. 52, no. 2, pp. 72–77, 2012. View at: Google Scholar
  20. L. Tanner, M. Schreiber, J. G. H. Low et al., “Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness,” PLoS Neglected Tropical Diseases, vol. 2, no. 3, article e196, 2008. View at: Publisher Site | Google Scholar
  21. C. C. Carlos, K. Oishi, M. T. D. D. Cinco et al., “Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines,” American Journal of Tropical Medicine and Hygiene, vol. 73, no. 2, pp. 435–440, 2005. View at: Google Scholar
  22. S. Pongpan, A. Wisitwong, C. Tawichasri, and J. Patumanond, “Prognostic indicators for dengue infection severity,” International Journal of Clinical Pediatrics, vol. 2, no. 1, pp. 12–18, 2013. View at: Google Scholar
  23. S. Sawasdivorn, S. Vibulvattanakit, M. Sasavatpakdee, and S. Iamsirithavorn, “Efficacy of clinical diagnosis of dengue fever in paediatric age groups as determined by WHO case definition 1997 in Thailand,” Dengue Bulletin, vol. 25, pp. 56–64, 2001. View at: Google Scholar
  24. World Health Organization, Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, World Health Organization, Geneva, Switzerland, 1997.
  25. K. Chang, P.-L. Lu, W.-C. Ko et al., “Dengue fever scoring system: new strategy for the early detection of acute dengue virus infection in Taiwan,” Journal of the Formosan Medical Association, vol. 108, no. 11, pp. 879–885, 2009. View at: Publisher Site | Google Scholar
  26. H. R. Iskandar, D. Mulyo, P. Agnes, and Y. Suryatin, “Comparison of pediatric logistic organ dysfunction (PELOD) score and pediatric risk of mortality (PRISM) III as a mortality predictor in patients with dengue shock syndrome,” Pediatrics, vol. 121, supplement 2, p. S129, 2008. View at: Google Scholar
  27. K. Oishi, C. A. Mapua, C. C. Carlos et al., “Dengue and other febrile illnesses among children in the Philippines,” Dengue Bulletin, vol. 30, pp. 26–34, 2006. View at: Google Scholar
  28. D. Thitiprayoonwongse, P. Suriyapkol, and N. Soonthornphisaj, “Data mining of dengue infection using decision tree,” in Latest Advances in Information Science and Applications: The 12th WSEAS International Conference on Applied Computer Science, pp. 154–159, 2012. View at: Google Scholar
  29. V. J. Lee, D. C. Lye, Y. Sun, and Y. S. Leo, “Decision tree algorithm in deciding hospitalization for adult patients with dengue haemorrhagic fever in Singapore,” Tropical Medicine and International Health, vol. 14, no. 9, pp. 1154–1159, 2009. View at: Publisher Site | Google Scholar

Copyright © 2013 Surangrat Pongpan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

4059 Views | 1401 Downloads | 4 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder